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BACKGROUND: Interpersonal trust plays an important
role in the clinic visit. Clinician trust in the patient may
be especially important when prescribing opioid analge-
sics because of concerns about misuse. Previous stud-
ies have found that non-white patients are perceived
negatively by clinicians.
OBJECTIVE: To examine whether clinicians’ trust in
patients differed by patients’ race/ethnicity in a socially
marginalized cohort.
DESIGN: Cross-sectional study of patient-clinician
dyads.
PARTICIPANTS: 169 HIV infected indigent patients
recruited from the community and their 61 primary
care providers (PCPs.)
MAIN MEASURES: The Physician Trust in Patients
Scale (PTPS), a validated scale that measures PCPs’
trust in patients.
KEY RESULTS: The mean PTPS score was 43.2 (SD
10.8) out of a possible 60. Reported current illicit drug
use and prescription opioid misuse were similar across
patients’ race or ethnicity. However, both patient illicit
drug use and patient non-white race/ethnicity were
associated with lower PTPS scores. In a multivariate
model, non-white race/ethnicity was independently
associated with PTPS scores 6.3 points lower than
whites (95% CI: −9.9, −2.7). Current illicit drug use
was associated with PTSP scores 5.5 lower than no drug
use (95% CI −8.5, −2.5).
CONCLUSION: In a socially marginalized cohort, non-
white patients were trusted less than white patients by
their PCPs, despite similar rates of illicit drug use and
opioid analgesic misuse. The effect was independent of
illicit drug use. This finding may reflect unconscious
stereotypes by PCPs and may underlie disparities in
chronic pain management.
KEY WORDS: trust; communication; vulnerable populations; opioid
analgesics; disparities.
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INTRODUCTION
Interpersonal trust is an important aspect of the clinical encoun-
ter.Trustisdefinedasone’sexpectationthatanotherwillbehavein
a particular way
1 and implies that both parties understand that
each others’ interests will not be violated
2. It reflects reliability,
understanding and information sharing, all key components of
high quality communication
3,4. In contrast to patients’ trust in
clinicians,
3,5clinicians’trust in patients has not been investigated.
While some clinical decisions are based on clear objective
measures, others, such as the treatment of chronic non-cancer
pain, are based on more subjective assessments. The treatment of
chronic pain is further complicated by the fact that while consider-
ation of opioid analgesics is reasonable for moderate to severe pain,
their use must be balanced against the risk of opioid misuse
6–9.
A number of patient characteristics are associated with an
increase risk of opioid analgesic misuse, including history of
alcohol abuse or illicit drug use
10–12. However, clinicians do not
conform their decisions to these well described risk factors.
Patients’race/ethnicityaffecttreatmentdecisions
13–15.Ad di ti o n-
ally, the treatment ofchronic painvariesbyclinicians’ experience
and training
8,16.
In qualitative studies, clinicians have identified mutual trust
as an important factor influencing chronic pain management
and the prescription of opioid analgesics
7,17–19. Clinicians judge
patients’ risk of misuse based on “gut feelings” rather than on
specific clinical characteristics associated with risk of misuse
17.
Thus, clinicians’ trust in their patients may play a large role in
decisions surrounding chronic pain management.
C h a r a c t e r i s t i c ss u c ha sp a t i e n t s ’ race/ethnicity may affect
clinicians’ trust. Studies have demonstrated that physicians
perceive African American patients more negatively
20. Assessing
therelationshipbetweenpatientrace/ethnicityandcliniciantrust
in the patient may be helpful in understanding the effect of race/
ethnicity on physician attitudes and behaviors. We analyzed a
cohortofsociallymarginalizedpatientswithHIVandtheirprimary
care providers in order to examine the association between race/
ethnicity and trust in a uniformly low SES population with high
rates of illicit drug use and prescription opioid analgesic misuse.
METHODS
Setting and Participants
In order to assess clinicians’ trust in patients, we conducted a
dyad study that involved a subset of community-based
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Springerlink.comindigent participants enrolled in a longitudinal observational
cohort study of pain (the Pain Study) and their primary care
providers (PCPs). We recruited participants for the Pain
Study from the Research on Access to Care in the Homeless
(REACH) study. The REACH study was a prospective cohort
of HIV-infected homeless and marginally housed adults in
San Francisco. The REACH cohort was recruited through
systematic sampling from homeless shelters, free-meal
programs, and single room-occupancy hotels
21,22 in three
waves (1996–1998, 1999–2000, and 2003). REACH partici-
pants were interviewed quarterly regarding illicit drug use,
housing status and healthcare utilization at a research
field site (University of California San Francisco’s Clinical
and Translational Sciences Institute Tenderloin Clinical
Research Center). For the Pain Study, we recruited all
REACH participants who completed study visits between
September 2007 and June 2008.
The Pain Study involved a baseline visit and seven
quarterly follow-up interviews that occurred every three
months coinciding with REACH follow-up quarterly inter-
views. For the Pain Study, participants completed a struc-
tured interview about pain, opioid analgesic use and misuse,
and health care utilization related to pain management. At
baseline, we conducted the Diagnostic Interview Schedule-IV
(DIS-IV)
23 substance and alcohol modules. At each follow-up
visit, participants completed the REACH questionnaire and
the Pain Study Follow-up Questionnaire, a 25-minute abbre-
viated version of the baseline questionnaire. Trained inter-
viewers administered all of the questionnaires, except for
questions about opioid analgesic misuse, which participants
completed using Audio Computer Assisted Self Interview
(ACASI) technology. ACASI is an acceptable method to use
with low-literacy populations and improves the reliability of
sensitive information
24.
We recruited one PCP for each participant who was active
in follow-up one year into the study. If a participant
provided informed consent to contact their PCP, and identi-
fied a provider who fit our definition (a medical doctor,
nurse practitioner (NP), or physician assistant (PA) in
outpatient practice providing longitudinal, comprehensive
care), we contacted the PCP and asked them to complete a
questionnaire about themselves and a separate question-
naire specific to each of their patients enrolled in the study.
The provider-specific questionnaire included questions
about the PCP’s demographics and practice characteristics.
The patient-specific questionnaire included questions about
the patient’s medical conditions, use and misuse of pre-
scription opioid analgesics, and the Physician Trust in
Patients Scale
25. We recommended, but did not require, that
PCPs refer to patient medical records when they completed the
survey. The study was approved by the University of California
San Francisco’s Institutional Review Board and patients and
PCPs provided written informed consent.
Independent Variables: Patient-Level
We obtained patient self-reported biological sex, date of birth,
race/ethnicity and history of incarceration in state or federal
prison at entry in the REACH cohort. We ascertained race/
ethnicity by having patients select racial or ethnic categories
from the following list: White, African American, Latino, Asian,
Native American, Pacific Islander, or mixed race. We collapsed
Asian, Native American, Pacific Islander and mixed race into a
single category due to the small number of respondents in
each of these categories. We measured alcohol abuse and
dependence through responses to the DIS-IV
23. In the DIS-IV,
alcohol abuse and dependence is defined in a manner
consistent with the Diagnostic and Statistical Manual of
Mental Disorders
26. We assessed current use of illicit drugs
using responses from the patient’s REACH questionnaire
completed closest in time to the PCP’s completed question-
naire. We defined current use as a “yes” response to questions
about use of cocaine, heroin or methamphetamines in the past
90 days. We combined use of cocaine, heroin or methamphet-
amine into a single variable, as we hypothesized that PCPs
would not distinguish between the three categories with regard
to trust
10.
We measured opioid analgesic misuse through patients’
responses to yes/no questions about specific misuse
behaviors using ACASI technology
27. Items addressed
using opioid analgesics to get high; trading them for
money, illicit drugs or sex; lying to their PCP about opioid
analgesics; forging prescriptions for opioids; or augmenting
the effect of prescription opioid analgesics with illicit drugs
or alcohol. We aggregated responses, defining misuse as an
affirmative answer to any one of these questions on the
Pain Study questionnaire completed closest in time to the
PCP survey.
Independent Variables: Clinician-Level
In addition to PCPs’ sex, age, race and ethnicity, we evaluated
years in practice and training (physician, PA or NP.) We asked
each PCP to estimate the proportion of their patient panel with
chronic pain. We collapsed PA and NP into a single category. We
collapsed PCP race and ethnicity into two categories, non-
Latino white and all others, owing to the small number of PCPs
who were of minority racial or ethnic groups. We recorded
years in practice as a categorical variable: 0 to 3, 4 to 9, 10 to
19 and 20 or greater.
Dependent Variable
We measured PCPs’ trust in patients with the Physician
Trust in the Patient Scale (PTPS), which was validated in the
Pain Study cohort
25. The PTPS has high internal reliability
with a Cronbach’s alpha of 0.93 and was shown to have
convergent validity with clinician reported perceptions of
patients’ b e h a v i o r se x p e c t e dt ob ea s s o c i a t e dw i t hl o w e r
levels of trust.
The PTPS consists of 12 questions that are rated on a 5-
point Likert scale with responses that range from (0, “not at
all confident”)t o( 5 ,“completely confident”)( Text Box). A total
score is the sum of the 12 items that can range from 0 to 60.
Higher scores indicate greater perceptions of trust.
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Our main analytic goal was to estimate the association of
patient race/ethnicity and PTPS scores. We selected indepen-
dent variables a priori that might confound the relationship
between patient race/ethnicity and PCPs’ trust in patients. We
entered all variables into the model simultaneously. After
testing confirmed that all non-white patient groups had lower
PTPS scores, we collapsed them for the multivariate analysis. We
analyzed bivariate and multivariate associations using general-
ized estimating equations, an extension of the linear model
providing robust standard errors, p-values, and confidence
intervals that account for the correlation among the multiple
responses of each PCP for a panel of patients
28,29.
RESULTS
Of the 296 patients initially enrolled in the Pain Study, 240 were
activeinthestudyatoneyearandprovidedwrittenconsent that
a l l o w e du st oc o n t a c tt h e i rP C P .W ec o n t a c t e dat o t a lo f9 0
PCPs for these patients of whom 61 PCPs returned
completed questionnaires for a total of 169 patients.
Two-thirds of patients were male (65.1%), half were
African American (46.8%), and their average age was
50 years. Approximately one quarter (27.8%) reported cur-
r e n tu s eo fi l l i c i td r u g s .A p p r o x i mately one quarter (22.5%)
reported misusing opioid analgesics in the past 90 days.
Most had experienced homelessness (82.0%) though few
were homeless at the time of the study (5.0%). Most had a
high school education or less (73.4%). The median annual
income was $11,280. PCPs were mostly white (78.3%).
Approximately half (46.0%) were male. The majority were in
practice between 10 and 19 years. None were in practice fewer
than four years. Most (83.6%) were physicians (Table 1).
The prevalence of current illicit drug use as well as opioid
analgesic misuse did not differ in a manner that was statistically
significant between racial or ethnic groups (p=0.71 and p=0.18
respectively). The mean PTPS score was 43.2 (SD 10.8.)
Bivariate models showed an association of both African Amer-
ican and “other” patient race with lower mean PTPS scores, as
well as an association between current illicit drug use, as
reported by the patient and lower mean PTPS scores (Table 1).
Bivariate models showed a trend towards lower PTPS scores
among patients who reported opioid analgesic misuse although
the effect did not reach statistical significance.
In the adjusted multivariate analysis, non-white patient race/
ethnicity was significantly associated with lower PTPS scores
(Table 2). Current drug use was also associated with lower PTPS
scores (p<0.01). Opioid analgesic misuse was not significantly
associated with differences in PTPS scores (p<0.01). PCPs with
more than 20 years in practice rated patients as having
significantlylowerPTPSscores(p<0.05).Thetestfortrendacross
categories was significant at p<0.05. The Wald statistic for the
multivariate model was 52.4 with p<0.001.
DISCUSSION
Our study found that in a cohort of socially marginalized
patients with HIV infection receiving primary care, PCPs
“How confident are you that this patient will…”
provide all the medical information you need? 
let you know when there has been a major change in his or her condition? 
tell you about all medications and treatments he or she is using? 
understand what you tell him/her? 
follow the treatment plan you recommend? 
be actively involved in managing his/her condition/problem? 
tell you if he/she is not following the treatment plan? 
respect your time? 
respect personal boundaries? 
not make unreasonable demands? 
not manipulate the office visit for secondary gain (e.g., for inappropriate disability 
certification or prescription of controlled substances)? 
keep his or her appointments?
Note: Response options were on a 5-point Likert scale ranging from “not at all 
confident” to “completely confident.”  Total scores were the sum of all 12 items, 
ranging from 0 to 60.
Text Box. Physician Trust in Patient Scale (PTPS) questions.
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and patients who were of non-white race/ethnicities. Our
findings are consistent with studies that suggest variations in
PCPs’ attitudes and prescribing decisions in different racial
groups with chronic pain
14,30. They extend the literature by
specifically investigating the construct of trust within a low
socioeconomic status cohort. In this sample, where every
patient is indigent and many have significant illicit substance
use and incarceration histories—and therefore is at higher
than average risk for opioid analgesic misuse—one might not
expect such variation in trust scores across different racial/
ethnic groups. Our finding of attitudes of distrust towards
non-white patients is consistent with studies of the general
population
31–33. In our study sample, rates of illicit substance
use and opioid analgesic misuse were similar among racial
groups. This finding is consistent with previous reports that
showed that African Americans are no more likely to misuse
prescription opioid analgesics than are whites
10.
Trust in patients represents an important component of the
clinical encounter and may serve as a provider-level mediator
of disparities in care
34. Even in this study of socially margin-
alized patients, PCPs’ trust in patients appears to be guided in
part by perceptions of racial/ethnic groups, and not solely by
individual patients’ illicit drug use or opioid analgesic misuse.
Trust is based on a subjective assessment of the patient, and
may be influenced by unconscious biases and stereotypes.
Clinical situations with high degrees of “cognitive load” (e.g.
risk, stress, uncertainty) generally increase providers reliance
on biases and stereotypes
35,36. Chronic pain management,
with the possibility of medication diversion and the simulta-
neous concern of under-treatment of pain, presents just such
a situation. Thus, PCPs’ differential trust of non-white
patients’ in a cohort of indigent patients might underlie well
demonstrated disparities in pain management
13,37–39.
The risk, uncertainty, and lack of objective findings that
typify the management of chronic pain are not unique to this
Table 2. Multivariate Model for Physicians’ Trust in Patients Scale
(PTPS) Scores
Change in PTPS score
(95% CI)
p
Patient
Female 3.1 (−1.1, 7.2) 0.15
Age (years) 0.1 (−0.1, 0.3) 0.45
Non-white -6.3 (−9.9, -2.7) <0.01
Opioid analgesic misuse
* -4.7 (−10.1, 0.7) 0.09
Current drug use
† -5.5 (−8.5, -2.5) <0.01
Lifetime alcohol abuse
or dependence
‡
1.2 (−1.7, 4.1) 0.42
Provider
Female -1.1 (−5.3, 3.1) 0.62
Non-white 0.6 (−3.3, 4.4) 0.76
Physician -2.7 (−7.9, 2.4) 0.29
Years in practice
4t o9 0 –
10 to 19 -2.6 (−7.7, 2.4) 0.31
> 20 -6.8 (−12.2, -1.5) 0.01
Clinic panel with chronic pain
Some 0 –
About half 0.3 (−3.6, 4.2) 0.88
Most to almost all 2.3 (−1.9, 6.5) 0.29
*Answering yes to any of the following in the past 90 days: using opioid
analgesics to get high; trading them for money, illicit drugs or sex; lying to
their PCP about opioid analgesics; forging prescriptions for opioids; or
augmenting the effect of prescription opioid analgesics with illicit drugs or
alcohol
†Answering “yes” to having used cocaine, heroin or methamphetamines
in the past 90 days
‡DIS-IV criteria
Table 1. Patient (n=169) and Provider (n=61) Demographic
Characteristics, and Unadjusted Association of Predictors with
Physicians’ Trust in Patients Scale (PTSP) Scores
n (%) PTPS score
(SE)
p
Total sample (mean, SD) – 43.2 (10.8) –
Patient age (years, SD) 49.5 (6.9) 0.1 (0.1)
* 0.52
Patient sex
Male 110 (65) 44 (1.1) –
Female 59 (35) 42 (1.5) 0.26
Annual income
(median, IQR)
11,280 (10,440,
11,904)
––
Education
Less than high school 49 (29) ––
Finished high school 75 (45) ––
Greater than high
school
44 (26) ––
Patient race/ethnicity
White 60 (36) 47.3 (1.4) –
African American 79 (47) 41.6 (1.2) <0.001
Latino 12 (7) 42.8 (2.5) 0.11
Other 13 (8) 35.9 (2.9) <0.001
Opioid analgesic
misuse
†
No 73 (43) 44.3 (2.0) –
Yes 96 (57) 39.7 (1.8) 0.03
Current drug use
‡
No 122 (72) 44.8 (1.0) –
Yes 47 (28) 39.2 (1.6) <0.01
Lifetime alcohol abuse
or dependence
§
No 68 (41) 43.3 (1.4) –
Yes 96 (59) 43.2 (1.27) 0.93
Lifetime history
of homelessness
136 (82) ––
Homeless at time
of interview
10 (5) ––
Incarceration (prison) 25 (16) ––
Provider sex
Male 28 (46) 44.1 (1.27) –
Female 33 (54) 42.5 (1.25) 0.35
Provider age (years, s.d.) 46.7 (8.3) ––
Provider race/ethnicity
White 47 (71) 43.2 (1.0) –
Non-white 13 (29) 43.3 (1.9) 0.97
Provider type
PA/NP 10 (16) 45.1 (1.8) –
MD 51 (84) 42.7 (1.0) 0.23
Years in practice
4 to 9 11 (18) 45.2 (2.6) –
10 to 19 31 (51) 43.6 (1.1) 0.57
> 20 19 (31) 41.9 (1.4) 0.28
Clinic panel with
chronic pain
Some 29 (48) 43.8 (1.4) –
About half 24 (39) 41.8 (1.3) 0.32
Most to almost all 8 (13) 45.3 (1.9) 0.52
*Change in PTPS per 1 year change in patient age
†Answering yes to any of the following in the past 90 days: using opioid
analgesics to get high; trading them for money, illicit drugs or sex; lying to
their PCP about opioid analgesics; forging prescriptions for opioids; or
augmenting the effect of prescription opioid analgesics with illicit drugs or
alcohol
‡Answering “yes” to having used cocaine, heroin or methamphetamines
in the past 90 days
§DIS-IV criteria
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care lack clear objective findings and are managed very
differently between providers. Therefore, it is likely that trust
in patients plays a role in many other clinical decisions.
Aside from clinical uncertainty, there are two characteristics
of trust in patients that make it particularly relevant to clinical
decision-making.First,theconstructoftrustisfutureoriented:it
involves an expectation of future actions
40,41. Especially in
primary care relationships that involve prevention or manage-
ment of chronic diseases, differential expectations of patients’
futureactionshavethepotentialtomodifyclinicaldecisionssuch
as medication intensification. Second, trust is closely related to
power. Communication strategies such as patient-centered
communication, where the patient’s perspective is elicited and
incorporated into decision making, requires sharing power and
responsibility
42. Clinicians’ trust of their patient is a necessary
step in this process
2. Differences in trust may affect the degree to
which patient-centered communication can be achieved.
PCPs who were in practice longer reported lower trust scores
of his or her patients. It is possible that an accumulation of
negative experiences with patients may lead to decreases in
trust. Alternatively, this association may represent broader
issues of decreased professional satisfaction, more prevalent
among older providers
43. Finally, while our study was under-
powered to explore whether the length of time in practice
differentially affected trust in patients by race/ethnicity, a third
potential explanation is that recent increased emphasis in
educational settings about disparities and biases/stereotypes
has led to more recently trained providers’ greater trust scores.
Our findings speak to the need to better train clinicians in
how to recognize and account for unconscious racial biases and
stereotypes. Unconscious attitudes represent an important
aspect of disparities education. Training about assumptions
and biases may be best integrated into teaching clinical
decision-making: increasing clinicians’ awareness of biases
and encouraging careful consideration of decisions based on
intuition. Alternatively, tests of implicit assumptions may serve
an educational role in increasing clinicians’ self-awareness of
unconscious biases
44.
Several limitations need to be acknowledged. The social
marginalization of patients (marginally housed, HIV infected,
with high rates of illicit drug use) limits the generalizability of
findings to other populations. Our sample size was relatively
small and, in particular, the number of non-white PCPs was
small. This limited our ability to analyze patient-clinician racial/
ethnic concordance, an important contributor to processes of
care
45. Finally, although socioeconomic status (SES) is a
common confounder of race and affects PCPs’ perceptions,
20
the uniformly low SES of the patients in this study decreases the
chance of SES confounding the relationship.
Findings from this study suggest that patients’ race/ethnicity
affects PCPs’ trust in patients in a socially marginalized cohort.
PCPs caring for similar populations should be aware of the
potential for both their trust in patients and their interpretation
of behaviors to be affected by unconscious racial biases. Our
findings add support for the implementation of standardized
policies regarding chronic pain management as an alternative to
management strategies that rely on PCP discretion. Policies such
as urine toxiciology and pain treatment agreements have the
potential to standardize care. However, recent evidence suggests
that their routine use should be reconsidered because of limited
evidence of their effectiveness
46. As new approaches to chronic
pain management are developed, close attention must be paid to
the role of providers’ unconscious biases, and the potential for
racial biases to be translated into disparities in care. Future
research on PCPs’ trust in patients should target its role as a
potential mediator of clinical decision-making, the role of PCP
race/ethnicity, aswellaswhetherourfindingsgeneralize toother
clinical settings and to less marginalized populations.
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